4//SEC Filing
O'Dowd Hugh 4
Accession 0001209191-21-054119
CIK 0000025743other
Filed
Aug 30, 8:00 PM ET
Accepted
Aug 31, 5:30 PM ET
Size
8.8 KB
Accession
0001209191-21-054119
Insider Transaction Report
Form 4
O'Dowd Hugh
President
Transactions
- Award
Restricted Stock Units
2021-08-31+2,750,000→ 2,750,000 totalExercise: $0.00→ Common Stock (2,750,000 underlying) - Award
Performance Stock Units
2021-08-31+2,750,000→ 2,750,000 totalExercise: $0.00→ Common Stock (2,750,000 underlying)
Footnotes (2)
- [F1]The performance stock units (PSUs) vest on August 31, 2024 based on the market capitalization of the issuer, which will be tested annually over three years beginning August 31, 2022 and are subject to the continuous service of the reporting person with the issuer. The number of PSUs listed is the maximum number of PSUs that may vest. The actual number of PSUs that will vest will be between zero and maximum number of PSUs, depending on the milestones achieved. Each PSU represents a contingent right to receive one share of common stock of the issuer.
- [F2]Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest in three equal installments annually beginning August 31, 2022, becoming fully vested on August 31, 2024, subject in each case to the continued service of the reporting person with the issuer.
Documents
Issuer
TherapeuticsMD, Inc.
CIK 0000025743
Entity typeother
Related Parties
1- filerCIK 0001741171
Filing Metadata
- Form type
- 4
- Filed
- Aug 30, 8:00 PM ET
- Accepted
- Aug 31, 5:30 PM ET
- Size
- 8.8 KB